Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
11/2000
11/15/2000EP1051502A2 HIGHLY EFFICIENT CONTROLLED EXPRESSION OF EXOGENOUS GENES IN $i(E. COLI)
11/15/2000EP1051500A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP1051488A2 Human growth factor homologs
11/15/2000EP1051479A1 Novel steroid-activated nuclear receptors and uses therefor
11/15/2000EP1051432A2 Method for reducing immunogenicity of proteins
11/15/2000EP1051427A1 Spoil protein and nucleic acid molecules and uses therefor
11/15/2000EP1051426A1 67 human secreted proteins
11/15/2000EP0832191A4 Recombinant viral nucleic acids
11/15/2000EP0828826A4 Plant promoter activated by fungal infection
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000EP0752102B1 Immunoenzymatic conjugate, preparation method therefor and uses thereof
11/15/2000EP0716710B1 Methods of suppressing immune response by gene therapy
11/15/2000EP0658168B1 Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
11/15/2000CN1273605A Mass production method of antimicrobial peptide and DNA construct and expression system thereof
11/15/2000CN1273602A Transgenic mammals which produce oligosaccharides in their milk
11/15/2000CN1273600A Avian primordial germ cell (PGC) cell line and method for long term culturing thereof
11/15/2000CN1273588A Amino acid sequences for therapeutical and prophylacticapplications to disedses due to i (clostridium difficile) toxinc
11/15/2000CN1273248A Efficient gene engineering process for preparing polypeptide medicines
11/15/2000CN1058524C Heat tolerant phytases
11/14/2000US6147282 Method of controlling the fertility of a plant
11/14/2000US6147203 Recombinant disulfide-stabilized polypeptide fragments having binding specificity
11/14/2000US6147202 Nucleotide sequences coding erythrocyte proteins; for utilization in blood transfusions
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147055 Cancer treatment method utilizing plasmids suitable for IL-2 expression
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146903 Method for determination of water treatment polymers
11/14/2000US6146885 Plasmid for transfer of genes into vertebrate cells
11/14/2000US6146870 Flea protease proteins
11/14/2000US6146853 Cyclic depsipeptide PF 1022G
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)
11/14/2000US6146836 Immunoassays using anti-allotypic monoclonal antibodies
11/14/2000US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects
11/14/2000US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample
11/14/2000US6146826 Green fluorescent protein
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/10/2000CA2307446A1 Complex for transferring an anionic substance of interest into a cell
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066778A1 Pituitrone gene and polypeptides
11/09/2000WO2000066761A2 Method of removing n-terminal alanine residues from polypeptides with aeromonas aminopeptidase
11/09/2000WO2000066756A1 Microbial protein expression system
11/09/2000WO2000066755A2 Pesticidal fusions
11/09/2000WO2000066753A2 Modified vitamin k-dependent polypeptides
11/09/2000WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000066738A1 Process for producing recombinant insulin from novel fused protein
11/09/2000WO2000066737A1 VARIANTS OF TRAF2 WHICH ACT AS AN INHIBITOR OF TNF-ALPHA (TNF α) SIGNALING PATHWAY
11/09/2000WO2000066736A1 Growth factor homolog zvegf4
11/09/2000WO2000066735A2 Human ion channel proteins
11/09/2000WO2000066732A2 Laminin 8 and methods for its use
11/09/2000WO2000066731A2 Recombinant laminin 5
11/09/2000WO2000066730A2 Laminin 2 and methods for its use
11/09/2000WO2000066727A1 Tumour-associated antigen
11/09/2000WO2000066726A1 Novel cellular regulation factor tto 20
11/09/2000WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000WO2000066718A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
11/09/2000WO2000066709A2 Zymogen activation system
11/09/2000WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/09/2000WO2000066631A1 SPECIFIC ANTIBODIES AND ANTIBODY FRAGMENTS FOR TGFβ¿1?
11/09/2000WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS
11/09/2000WO2000066627A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000WO2000066178A1 Lim mineralization protein splice variants
11/09/2000WO2000066160A1 Parenteral medicinal composition containing humanized monoclonal antibody fragment and method for stabilizing the same
11/09/2000WO2000066156A1 Death domain containing receptor 5
11/09/2000WO2000066143A1 Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
11/09/2000WO2000066067A2 Ibd-associated microbial antigens and methods of using same
11/09/2000WO2000040705A3 Human desaturase gene and uses thereof
11/09/2000WO2000039323A3 Production of proteins in gram-positive microorganisms
11/09/2000WO2000037638A3 Methods and compositions for inhibiting neoplastic cell growth
11/09/2000WO2000037489A3 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
11/09/2000WO2000036102A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/09/2000WO2000034477A3 Neuron-associated proteins
11/09/2000WO2000034475A3 Grnf4, a gdnf-related neurotrophic factor
11/09/2000WO2000034447A3 Human ubiquitin ligase e3 for the modulation of nf-kappa b
11/09/2000WO2000032794A3 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000WO2000032624A3 Uncoupling protein 5 - ucp5
11/09/2000WO2000031235A3 Nucleotide and protein sequences of nogo genes and methods based thereon
11/09/2000WO2000029564A3 Human glycine transporter type 2
11/09/2000WO2000028034A3 Cytokine signal regulators
11/09/2000WO2000024780A3 Compositions and methods for treating polycystic kidney disease
11/09/2000WO2000024771A3 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
11/09/2000WO2000023565A3 Novel neuropilin/growth factor binding and uses thereof
11/09/2000WO2000015785A3 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN
11/09/2000WO2000006737A8 Streptococcus pneumoniae proteins and nucleic acid molecules
11/09/2000DE19921027A1 Verbindungen mit antibiotischer Wirkung Compounds with antibiotic activity
11/09/2000DE19920816A1 Cephaibole, neue Antiparasitika aus Acremonium tubakii, Verfahren zu ihrer Herstellung und Verwendung derselben Cephaibols new antiparasitic drugs from Acremonium tubakii, processes for their preparation and use thereof
11/09/2000CA2407714A1 Expression of heparin-binding protein in recombinant mammalian cells
11/09/2000CA2373021A1 Chlamydia antigens and corresponding dna fragments and uses thereof
11/09/2000CA2373018A1 Novel cellular regulation factor tto 20
11/09/2000CA2372923A1 Dna encoding snorf36a and snorf36b receptors
11/09/2000CA2372907A1 Zymogen activation system
11/09/2000CA2372803A1 Variants of traf2 which act as an inhibitor of tnf-alpha (tnf .alpha.) signaling pathway
11/09/2000CA2372221A1 Methods for producing recombinant insulin from novel fusion proteins
11/09/2000CA2372192A1 Lim mineralization protein splice variants
11/09/2000CA2371596A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof
11/09/2000CA2371577A1 Forms of prostate specific antigen (psa) specific for benign prostatic hyperplasia (bph) and methods of using such
1 ... 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 ... 1125